WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles
Zhongjin: The contradiction between supply and demand in overseas electricity is prominent, and Chinese manufacturers are welcoming an accelerated period of going global.
EB SECURITIES: How to view February's significantly lower-than-expected non-farm data?
Oracle Corporation (ORCL.US) abandons its plans to expand data centers in Texas, OpenAI or Meta (META.US) may take over the project.
Zhongjin: The contradiction between supply and demand in overseas electricity is prominent, and Chinese manufacturers are welcoming an accelerated period of going global.
EB SECURITIES: How to view February's significantly lower-than-expected non-farm data?
Oracle Corporation (ORCL.US) abandons its plans to expand data centers in Texas, OpenAI or Meta (META.US) may take over the project.
RECOMMEND
